‘Shizu Saldamando: L.A. Intersections’ at Occidental College
v?n có s? ch? ng?i t?i ?a lên ??n 9.
Giá USD ? các ngan hàng th??ng m?i sáng nay (30/8) ???c niêm y?t ph? bi?n ? m?c 24.T?i Doji Hà N?i và TPHCM.
S? li?u này cho th?y.??u phiên giao d?ch 30/8.theo gi? Vi?t Nam) giao d?ch ? m?c 2.
vàng th? gi?i quy ??i theo giá USD ngan hàng ? m?c g?n 76.l??ng nh?p kh?u vàng c?a Trung Qu?c b?t ??u t?ng 17% trong tháng 7.
T? giá trung tam ngày 30/8/2024 ???c Ngan hàng Nhà n??c c?ng b? là 24.
??n xin tr? c?p th?t nghi?p c?a M? gi?m khi?n vàng kém h?p d?n: ?nh: Hoàng Hà??u phiên giao d?ch ngày 29/8 (theo gi? M?).l?i ích h?p pháp c?a c?ng dan Vi?t Nam.
l??ng caoLiên quan ??n nh?ng c?ng dan b? l?a.Báo chí Campuchia th?ng tin: V?a qua 195 ng??i n??c ngoài b? tr?c xu?t sau cu?c truy quét các c? s? c? b?c tr?c tuy?n b?t h?p pháp ? Sihanoukville.
18 c?ng dan b? b?t gi? do hành vi tham gia t? ch?c trò ch?iAuthoritiesinspectapharmacyinTanPhúDistrict,HCMCity.—VNA/VNSPhoto?inhTh?H?ngHàN?I—ArevisedversionoftheLawonPharmaceuticals2016willbepresentedtotheNationalAssemblyfordiscussionandfeedbackduringalegislativemeetingfromJune17to28.AccordingtotheDrugAdministrationofVietnam,theversionenactsspecialmechanismsforusingmedicinesandvaccinesduringaCOVID-19outbreak,ensuringastablepharmaceuticalsupplyincaseoffutureoutbreaks.Anotherfocusisintroducingmorerobustpoliciestoattractinvestment,promoteresearchanddevelopmentindrugmanufacturingandacceleratetechnologytransfersinspecialisedmedicines.Accessibilityisalsoakeytheme.Theversionaimstodiversifypharmaceuticalsupplybyestablishingalegalframeworkforpharmacychainsandpharmaceuticalsalesone-commerceplatforms.Additionally,itgrantspharmaceuticalbusinesslicencestonon-profitpharmaceuticalentitiesthatengageincommercialactivitiestoensureessentialmedicinesreachawiderrangeofthepopulation.Italsoaimstoempowerforeign-investedenterprises(FIEs)toplayamoreactiveroleinVi?tNamsmedicinesupplychains.ThisincludesallowingFIEstodirectlydistributepharmaceuticalstheyhavemanufactured,contractmanufactured,orforwhichtheyhavetransferredtechnologyinVi?tNam.Italsoaimstosimplifyregistrationproceduresbystreamliningfileextensions,definingscenariosforregistrationwithoutthePharmaceuticalRegistrationAdvisoryCouncilsandMinistryofHealthsapprovals,andreducingfileprocessingtimefromthreemonthsto15daysandlicenceissuingtimefrom12monthstoninemonths.ItalsoallowscontinueduseofexpireddrugregistrationlicencesifrenewalapplicationshavebeensubmitteduntilrenewalortheMinistryofHealthsnotificationisreceived.Thisaimstoensureuninterruptedpharmaceuticalcirculationandpreventsupplydisruptions.Forfearthattheprevalenceofregistered-but-not-circulatedpharmaceuticalscouldobscurethetruepictureofdrugavailability,theversionlimitstherenewaloflicencesforpharmaceuticalsthathavenotbeencirculatedforfiveyears,exceptforsometypesofmedicines.ItalsodecentralisesrecallauthoritytoprovincialDepartmentsofHealthforpharmaceuticalswithqualityissuesoflevel2orlevel3withintheirjurisdiction.Thiswouldexpeditelocalrecallactionsandalignwithregulationsonproductqualityinspection.AnotherfocusinvolvesGoodManufacturingPractices(GMP).TheversionadoptsinternationalGMPstandardsasthebasisforevaluatingforeignpharmaceuticalfacilities,ensuringareliablesupplyofrawmaterialsforVietnamesemanufacturers.Italsostreamlinesadministrativeproceduresandreducescertainbusinessrequirementstogivemoreelbowroomtopharmaceuticalenterprises.ThisincludeseliminatingconfirmationproceduresandallowingmanufacturerstoimplementqualitymanagementmeasuresbasedonGMPprinciples.Italsoreinforcespharmaceuticalpricemanagementbyregulatingdeclarationpricesandprojectedwholesalepricestominimiseintermediaries.Proceduresforregistrationofnewdrugs,brand-namedrugs,specialisedtreatmentdrugs,biologicalproducts,high-techdrugs,andrawmaterialsfordrugsproducedbasedonnationallyapprovedscientificandtechnologicaltasks,andbiotechnologicaldrugswithtechnologytransferforproductioninVi?tNam,genericdrugsofnewdrugswhosepatentprotectionisabouttoexpire,aswellastraditionalmedicinesproducedusinghigh-techprocessesandfromsourcesofmedicinalherbsmeetingGACP-WHOstandards,willbestreamlinedunderthenewproposedlaw.Raredrugs,WHOprequalifiedvaccines,anddrugsthathaveundergoneclinicaltrialsinVi?tNam,willalsobegrantedimportlicences.Nguy?nThanhLam,DeputyDirectoroftheDrugAdministrationofVietnam,saidtheLawonPharmaceuticals2016hadestablishedastrongregulatoryframeworkforpharmaceuticalsforyears.However,thegrowingdemandforhigh-qualitymedicinesandtheemergenceofnewdiseaseshaveexposedtheneedforrevisionstotheLawtokeepmanufacturersupwiththetimes.Thisrevisedversionwilladdresscurrentshortcomingsinpharmaceuticalmanagement,pavingthewayfortheindustryscontinuedgrowthandensuringaccessibilitytohigh-qualityandaffordablepharmaceuticals,saidLam.—VNS